Raleigh Capital Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79K Buy
+54
New +$1.61K ﹤0.01% 556
2025
Q1
Sell
-1,728
Closed -$52K 1006
2024
Q4
$52K Hold
1,728
0.02% 312
2024
Q3
$40.4K Hold
1,728
0.02% 348
2024
Q2
$30.7K Hold
1,728
0.01% 367
2024
Q1
$26.3K Buy
1,728
+300
+21% +$4.78K 0.01% 391
2023
Q4
$24.4K Buy
1,428
+200
+16% +$2.32K 0.01% 401
2023
Q3
$10.3K Buy
1,228
+63
+5% +$878 0.01% 509
2023
Q2
$28.9K Hold
1,165
0.01% 318
2023
Q1
$17.5K Hold
1,165
0.01% 396
2022
Q4
$13.8K Buy
1,165
+200
+21% +$1.45K 0.01% 375
2022
Q3
$6K Buy
965
+90
+10% +$590 ﹤0.01% 462
2022
Q2
$4K Buy
875
+200
+30% +$1.25K ﹤0.01% 486
2022
Q1
$6K Buy
+675
New +$7.81K ﹤0.01% 439

Other funds holding TGTX